ICU Medical Inc
NASDAQ:ICUI
ICU Medical Inc
NASDAQ:ICUI
Price:
103.99 USD
-2.15%
Market Closed
Updated:
May 19, 2024
ICU Medical Inc
Cost of Revenue
|
ICU Medical Inc
Cost of Revenue Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Cost of Revenue
-$1.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-25%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Cost of Revenue
-$1.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cost of Revenue
-$1.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cost of Revenue
-$1.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-22%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cost of Revenue
-$491.4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-9%
|
See Also
What is ICU Medical Inc's Cost of Revenue?
Cost of Revenue
-1.5B
USD
-1.5B
USD
Based on the financial report for Mar 31, 2024, ICU Medical Inc's Cost of Revenue amounts to -1.5B USD.
What is ICU Medical Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-25%
-25%
Over the last year, the Cost of Revenue growth was 4%. The average annual Cost of Revenue growth rates for ICU Medical Inc have been -24% over the past three years , -14% over the past five years , and -25% over the past ten years .
You don't have any saved screeners yet
